# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BMO Capital analyst Evan Seigerman downgrades Incyte (NASDAQ:INCY) from Market Perform to Underperform and lowers the price ...
Cantor Fitzgerald analyst Eric Schmidt reiterates Incyte (NASDAQ:INCY) with a Neutral.
The Nasdaq 100 index posted its fourth consecutive session in the green on Thursday, closing at 19,576 points and reaching all-...
Incyte Corporation (NASDAQ:INCY) ("Incyte" or the "Company") announced today the preliminary results of its mod...
Hedge funds are looking for high-return opportunities beyond the mega-cap tech giants preferring to focus on cyclical sectors a...